The Food and Drug Administration added a warning information sheet Johnson & Johnson for the COVID-19 vaccine, saying the shot could lead to an increased risk of Guillain-Barré syndrome. According to the agency, the benefits of the vaccine still outweigh the risks.
Of the approximately 12.6 million people vaccinated with Johnson & Johnson, about 100 syndromes have been reported, the Centers for Disease Control and Prevention said in a statement. that Washington Post. It’s a very rare complication, but people who have been shot seem to be close 3-5 times more likely to have Guillain – Barré syndrome than the general population.
There are no indications that Moderna or Pfizer / BioNTech vaccines have a similar risk.
In Guillain-Barré syndrome, the body’s immune system attacks the nerves. It can cause tingling, weakness, and coordination problems in the hands and feet. Most people recover completely, but in some cases, it can lead to permanent nerve damage.
The syndrome has been linked to vaccines in the past. United States stopped using swine flu vaccine in 1976 after reports that the people who took the vaccine developed Guillain-Barré. In what years it exists small increased risk syndrome with a seasonal flu vaccine – usually about one or two additional cases for every million flu shots given. The CDC notes that people may be more likely to develop Guillain-Barré from influenza than from influenza.
This is another health risk associated with the Johnson & Johnson vaccine. U.S. health agencies recommended suspending the administration shot in April after it was associated with a rare coagulation disorder. The company added a warning about the risk of disruption, and the break disappeared after 10 days.
Agencies have not recommended discontinuing the vaccine this time. The vaccine is still available and simply has an extra warning label. People living in the United States also receive Moderna and Pfizer / BioNTech vaccines.
Experts hoped Johnson & Johnson’s shot would play an important role in the U.S. vaccination campaign, as it would take only one dose instead of the two doses needed for Moderna or Pfizer / BioNTech. So far, it has been given less than 10 percent People vaccinated in the United States.
The number of people vaccinated daily in the United States has dropped to about 500,000 from an April peak of about 3 million. There are COVID-19 cases began to climb again because the Delta transformation is sticking around the country.